Dermatomyositis

DURHAM, N.C., Aug 26, 2026 Priovant Therapeutics announced the publication of skin-specific outcomes from the Phase 3 VALOR trial...

SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, Aug 24, 2026 United Therapeutics Corporation announced that the U.S....

ELK GROVE VILLAGE, Illinois, Aug 28, 2026 Orsini announced that it will serve as a specialty pharmacy partner for...

SILVER SPRING, MARYLAND, Aug 27, 2026 Priovant Therapeutics Inc. has received U.S. Food and Drug Administration (FDA) approval for...

SHANGHAI, China / CAMBRIDGE, Massachusetts / AMSTERDAM, Netherlands — August 17, 2026 Zai Lab Limited and argenx announced positive...

Amsterdam, Netherlands, August 17, 2026 argenx SE announced positive topline results from the Phase 3 ALKIVIA study evaluating VYVGART...

SAN DIEGO, California, July 13, 2026 Aethlon Medical, Inc. has announced encouraging interim findings from the second patient cohort...

DUBLIN, Ireland, July 13, 2026 Keenova Therapeutics plc has announced the publication of a new peer-reviewed real-world evidence study...